ɪn ɐ ɹᵻsˈɜːtʃ stˈʌdi baɪ vˈeɪʃnævi ˈeɪ. ˈɛt ˈæl., ˌɛntˌiːˌɑːɹkˈeɪ wˈʌn fjˈuːʒənz ɑːɹ ˈɛstᵻmˌeɪɾᵻd tʊ əkˈɜːɹ ɪn θɹˈiː.θɹˈiː pɚsˈɛnt ʌv lˈʌŋ kˈænsɚɹ æz ɐsˈɛst θɹuː nˈɛkst dʒˌɛnɚɹˈeɪʃən sˈiːkwənsɪŋ ɔːɹ flʊɹɹˈɛsəns ɪn sˈɪɾuː hˌaɪbɹɪdᵻzˈeɪʃən.
In a research study by Vaishnavi A. et al., NTRK1 fusions are estimated to occur in 3.3% of lung cancer as assessed through next generation sequencing or fluorescence in situ hybridization.